DERIVATE VON AMPHOTERICIN B
European patent · EP3283171 · In force
Register entry
- Publication number
- EP3283171
- Application number
- EP16780813
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 15, 2016
- Published
- Feb 21, 2018
- Granted
- May 26, 2021
- Protection ends at the latest
- Apr 14, 2036
- Next annual fee due
- Apr 30, 2026
- IPC classes
- C07H 17/08 (2006.01)A61P 31/10 (2006.01)A61P 31/04 (2006.01)
- Priority
- US 201562147949 P 15.04.2015
- PCT application
- PCT/US2016/027703 15.04.2016
- PCT publication
- WO2016/168568 20.10.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 1, 2025
Change
Published in Swissreg on 01.05.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- Apr 6, 2022
Change
Published in Swissreg on 06.04.2022
- Jul 14, 2021
Agent entered
- Representative
- HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 14.07.2021
- May 26, 2021
Granted
Published in Swissreg on 26.05.2021
Parties
Inventor
BURKE, Martin D.
Champaign, IL 61821, US
THOTTUMKARA, Arun P.
Menlo Park, CA 94025, US
SWEENEY, Zachary K.
Redwood City, CA 95062, US
MELLEM, Kevin T.
Redwood City, CA 94063, US
KOLTUN, Elena S.
Foster City, CA 94404, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.